Description

ZOPISIGN 10 TABLET is a high-strength prescription medication formulated with Zopiclone 10 mg, a non-benzodiazepine hypnotic agent that works directly on the central nervous system to initiate sleep, extend sleep duration, and reduce nocturnal awakenings. It is especially suitable for individuals who have chronic insomnia or moderate to severe difficulty staying asleep through the night.

Zopiclone belongs to the cyclopyrrolone class and interacts with GABA-A receptors in the brain to produce calming, sedative effects without significantly altering the architecture of natural sleep. This ensures patients experience restorative rest without daytime grogginess when used as prescribed.

Manufactured in WHO-GMP, FDA, and ISO-certified facilities under the highest quality control standards, ZOPISIGN 10 TABLET is offered worldwide by BLUEPILL EXPRESS—a trusted global name in third-party manufacturing and bulk pharmaceutical export. BLUEPILL EXPRESS serves healthcare systems across Asia, Africa, Latin America, the Middle East, and CIS countries, offering customized branding, packaging, and regulatory support for international buyers.

• Hypnotic and sedative (Non-benzodiazepine class)

• CNS depressant for sleep initiation and maintenance

Zopiclone enhances the action of gamma-aminobutyric acid (GABA), the brain’s primary inhibitory neurotransmitter. By binding to GABA-A receptor sites, Zopiclone calms overactive brain activity, enabling users to fall asleep faster, stay asleep longer, and wake up feeling more refreshed.

• Severe or chronic insomnia

• Difficulty falling or staying asleep

• Sleep maintenance disorder

• Insomnia related to anxiety or psychiatric conditions

• Jet lag or shift-work-related sleep issues

• Stronger formulation for severe or chronic insomnia

• Promotes rapid sleep onset within 20–30 minutes

• Minimizes nighttime awakenings and improves sleep depth

• Maintains natural sleep cycles (REM and non-REM)

• Exported globally by BLUEPILL EXPRESS with full regulatory compliance

• Ideal for hospital and pharmacy distribution in semi-regulated and regulated markets

• Standard adult dose: One tablet (10 mg) taken just before bedtime

• Ensure 7–8 hours of undisturbed sleep opportunity post-dose

• Not to be used continuously beyond 7–10 days without medical review

• Avoid combining with alcohol or other sedatives

• Not for long-term use without clinical supervision

• May cause drowsiness, dizziness, or reduced alertness

• Use cautiously in elderly or patients with liver/respiratory impairment

• Risk of dependence or withdrawal symptoms with misuse

• Contraindicated during pregnancy and lactation unless advised by a physician

• Bitter or metallic taste

• Dry mouth

• Drowsiness or dizziness the next morning

• Nausea, headache

• Rare: parasomnias (e.g., sleepwalking), confusion, or mood changes

Seek medical attention if serious adverse effects or allergic reactions occur.

BLUEPILL EXPRESS is a trusted global third-party manufacturer and exporter of high-quality pharmaceutical products. With expertise in regulatory documentation, bulk supply, and brand-neutral or private-labeled formulations, we ensure efficient, compliant, and scalable solutions for your pharmaceutical sourcing needs.

ZOPISIGN 10 TABLET is part of BLUEPILL EXPRESS’s neuropsychiatric product portfolio, offering reliable CNS therapeutics for domestic and international partners, hospitals, wholesalers, and distributors. Backed by rigorous quality standards, our Zopiclone products are shipped in customized packaging, complete with COAs, MSDS, stability data, and logistics support.